A study to investigate efficacy of lenalidomide-dexamethasone in patients with AL amyloidosis with relapsed or refractory clonal disease.
Phase of Trial: Phase IV
Latest Information Update: 02 Dec 2015
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
- 02 Dec 2015 New trial record